A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Active, not recruitingOBSERVATIONAL
Enrollment

583

Participants

Timeline

Start Date

August 13, 2020

Primary Completion Date

February 23, 2026

Study Completion Date

February 23, 2026

Conditions
Plasma Cell Myeloma
Interventions
DRUG

isatuximab SAR650984

"Pharmaceutical form: solution for infusion~Route of administration: intravenous"

DRUG

Pomalidomide

Pharmaceutical form: oral

DRUG

Dexamethasone

Pharmaceutical form: oral

DRUG

Carfilzomib

Pharmaceutical form: solution for infusion

Trial Locations (129)

100

Investigational Site Number : 1580001, Taipei

1070

Institut Jules Bordet - Investigational Site Number : 0560001, Anderlecht

1199

Investigational Site Number : 0320001, Ciudad Autonoma Buenos Aires

3010

Investigational Site Number : 5760001, Bern

4400

LKH Steyr - Investigational Site Number : 0400002, Steyr

5404

Kantonsspital Baden AG - Investigational Site Number : 5760003, Baden

7400

Investigational Site Number : 7840001, Abu Dhabi

8063

Stadtspital Triemli - Investigational Site Number : 5760002, Zurich

9100

AZ Nikolaas - Investigational Site Number : 0560002, Sint-Niklaas

10117

Investigational Site Number : 2760003, Berlin

10437

Investigational Site Number : 2760041, Berlin

10715

Praxis am Volkspark - Investigational Site Number : 2760009, Berlin

11001

Investigational Site Number : 7840002, Abu Dhabi

11426

Investigational Site Number : 6820002, Riyadh

12200

Investigational Site Number : 2760022, Berlin

14467

Klinikum Ernst von Bergmann gGmbH -Investigational Site Number : 2760039, Potsdam

17036

Dietrich-Bonhoeffer-Klinikum - Investigational Site Number : 2760044, Neubrandenburg

18012

Hospital Universitario Virgen de la Nieves - Investigational Site Number : 7240010, Granada

18537

Investigational Site Number : 3000005, Piraeus

20132

Investigational Site Number : 3800003, Milan

21423

Investigational Site Number : 6820005, Jeddah

24071

Complejo Asistencial Universitario de Leon Altos de Nava s/n. -Investigational Site Number : 7240005, León

25123

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia - Investigational Site Number : 3800007, Brescia

26121

Investigational Site Number : 2760021, Oldenburg

26133

Investigational Site Number : 2760036, Oldenburg

27100

Investigational Site Number : 3800013, Pavia

27103

Novant Health Forsyth Medical Center Site Number : 8400028, Winston-Salem

28100

Investigational Site Number : 3800008, Novara

29010

Hospital Regional Universitario de Malaga Hospital Regional Universitario de Malaga - Investigational Site Number : 7240006, Málaga

29414

Charleston Hematology Oncology Associates, PA Site Number : 8400020, Charleston

29615

Prisma Health - Eastside Office Site Number : 8400011, Greenville

30449

Investigational Site Number : 2760012, Hanover

31008

Hospital Universitario de Navarra - Investigational Site Number : 7240009, Pamplona

31100

Investigational Site Number : 3800010, Treviso

32204

GenesisCare Site Number : 8400007, Jacksonville

33024

Millennium Oncology Site Number : 8400025, Pembroke Pines

33308

Holy Cross Hospital Site Number : 8400030, Fort Lauderdale

33604

Investigational Site Number : 2500009, Pessac

33709

Comprehensive Hematology Oncology Site Number : 8400026, St. Petersburg

33805

Watson Clinic Cancer and Research Center Site Number : 8400023, Lakeland

34234

Investigational Site Number : 6820001, Khobar

34295

Investigational Site Number : 2500004, Montpellier

35037

Philipps-Universitat Marburg, Klinic fur Innere Medizin -Investigational Site Number : 2760038, Marburg

36001

Complejo Hospitalario Universitario de Pontevedra - Investigational Site Number : 7240011, Pontevedra

38122

Investigational Site Number : 3800004, Trento

38320

omplejo Hospitalario Universitario de Canarias - Investigational Site Number : 7240007, San Cristóbal de La Laguna

40138

Istituto di Ematologia e Oncologia Medica - Investigational Site Number : 3800005, Bologna

42262

Investigational Site Number : 4140001, Kuwait City

42270

Investigational Site Number : 2500005, Saint-Priest-en-Jarez

44263

GEFOS Gesellschaft f. onkologische Studien -Investigational Site Number : 2760001, Dortmund

44646

Tri County Hematology & Oncology Associates, Inc Site Number : 8400012, Massillon

44708

Hematology & Oncology Associates Site Number : 8400015, Canton

45003

Investigational Site Number : 7240004, Toledo

46000

Investigational Site Number : 2500017, Cahors

48334

Michigan Center of Medical Research Site Number : 8400010, Farmington Hills

50677

MV Zentrum für Onkologie und Hämatologie - Investigational Site Number : 2760034, Cologne

51092

CHU Reims - Hôpital Robert Debré - Investigational Site Number : 2500010, Reims

52222

Investigational Site Number : 2760040, Stolberg

54270

Clinique Louis Pasteur, Maison Médicale - Investigational Site Number : 2500012, Essey-lès-Nancy

56017

Investigational Site Number : 2500011, Vannes

59800

Investigational Site Number : 2500013, Lille

60389

Onkologische Gemeinschaftspraxis am Bethanien-Krankenhaus - Investigational Site Number : 2760010, Frankfurt am Main

60596

Investigational Site Number : 2760037, Frankfurt

63739

Investigational Site Number : 2760016, Aschaffenburg

64114

AMR Kansas City Site Number : 8400016, Kansas City

65013

Investigational Site Number : 2500016, Tarbes

67846

Central Care Cancer Center Site Number : 8400019, Garden City

Central Care Cancer Center Site Number : 8400006, Garden City

70124

Investigational Site Number : 3800006, Bari

72037

Centre Hospitalier Le Mans - Investigational Site Number : 2500015, Le Mans

73000

Centre Hospitalier Metropole Savoie - Investigational Site Number : 2500006, Chambéry

73557

Klinikum Schwaebisch Gmuend - Investigational Site Number : 2760042, Mutlangen

76038

Investigational Site Number : 2500001, Rouen

77380

Renovatio Clinical Site Number : 8400004, The Woodlands

80138

"Azienda Ospedaliera Universitaria Federico II-Investigational Site Number : 3800001", Napoli

81241

Investigational Site Number : 2760006, München

82211

Investigational Site Number : 2760013, Herrsching am Ammersee

82362

Investigational Site Number : 2760031, Weilheim

86021

CHU Poitiers - Hôpital la Milétrie - Investigational Site Number : 2500008, Poitiers

86609

Investigational Site Number : 2760007, Donauwörth

92835

St. Joseph Heritage Healthcare Site Number : 8400008, Fullerton

94143

University of California San Francisco (PARENT) Site Number : 8400009, San Francisco

95107

Centre Hospitalier Victor Dupouy - Investigational Site Number : 2500007, Argenteuil

95326

Klinikum Kulmbach mit Fachklinik Stadtsteinach - Investigational Site Number : 2760026, Kulmbach

95445

Investigational Site Number : 2760018, Bayreuth

96052

Investigational Site Number : 2760020, Bamberg

97070

Investigational Site Number : 2760019, Würzburg

400138

Investigational Site Number : 6430006, Volgograd

510120

Investigational Site Number : 1560002, Guangzhou

518053

Investigational Site Number : 1560001, Shenzhen

833401

Investigational Site Number : 1580002, Kaohsiung City

72205-7199

University of Arkansas Medical Sciences Site Number : 8400021, Little Rock

04240

Central Maine Medical Center Site Number : 8400031, Lewiston

07728

Regional Cancer Care Associates, LLC - Freehold Division Site Number : 8400017, Freehold

07731

Regional Cancer Care Associates Site Number : 8400024, Howell Township

07739

Regional Cancer Care Associates - Little Silver Division Site Number : 8400018, Little Silver

57201-1548

Prairie Lakes Health Care System, Inc Site Number : 8400002, Watertown

77030-4000

MD Anderson Cancer Center Site Number : 8400013, Houston

B1629ODT

Investigational Site Number : 0320006, Pilar

C1118AAT

Investigational Site Number : 0320004, Buenos Aires

X5000JHQ

Investigational Site Number : 0320005, Córdoba

X5016KEH

Investigational Site Number : 0320002, Córdoba

02321

Investigational Site Number : 2500014, Saint-Quentin

01127

Investigational Site Number : 2760002, Dresden

01307

Investigational Site Number : 2760035, Dresden

04289

Investigational Site Number : 2760008, Leipzig

Unknown

Investigational Site Number : 3440001, Hong Kong

00133

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia - Investigational Site Number : 3800009, Rome

00137

Azienda Ospedaliera Universitaria Policlinico Umberto I - Investigational Site Number : 3800002, Rome

003-0006

Investigational Site Number : 3920012, Sapporo

543-8555

Investigational Site Number : 3920009, Osaka

411-8777

Investigational Site Number : 3920003, Sunto-gun

105-8470

Investigational Site Number : 3920004, Minato-ku

815-8555

Investigational Site Number : 3920010, Fukuoka

105-8471

Investigational Site Number : 3920013, Minatoku

701-1192

Investigational Site Number : 3920005, Okayama

589-8511

Investigational Site Number : 3920014, Osakasayama-shi

377-0280

Investigational Site Number : 3920008, Shibukawa-shi

392-8510

Investigational Site Number : 3920011, Suwa-shi

990-9585

Investigational Site Number : 3920001, Yamagata

3318 AT

Albert Schweitzer Ziekenhuis - Investigational Site Number : 5820001, Dordrecht

00917

Puerto Rico Medical Research Center, LLC Site Number : 8400001, Hato Rey

Auxilio Mutuo Cancer Center Site Number : 8400029, San Juan

23431 6688

Investigational Site Number : 6820004, Jeddah

07120

Hospital Universitari Son Espases - Investigational Site Number : 7240003, Palma de Mallorca

NG5 1PB

Investigational Site Number : 8260002, Nottingham

SM2 5PT

Investigational Site Number : 8260005, Sutton

HD3 3EA

Huddersfield Royal Infirmary - Investigational Site Number : 8260004, Huddersfield

NE7 7DN

Freeman Hospital - Investigational Site Number : 8260003, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT04458831 - A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) | Biotech Hunter | Biotech Hunter